Home / Health / UK Trial: Prostate Screening for Black Men Begins
UK Trial: Prostate Screening for Black Men Begins
4 Jun
Summary
- Black men aged 45-74 will be invited for prostate cancer checks.
- The initiative is part of a UK trial to improve screening methods.
- A man whose twin died believes the trial is too late for his brother.
In a significant development for public health, Black men in the UK aged 45 to 74 will now be invited to participate in a groundbreaking prostate cancer screening trial. This initiative, announced by the government, represents a pivotal step in refining diagnostic approaches for the disease.
Charities and advocacy groups have lauded this decision as a "truly historic moment." However, for individuals like Dave Cossie, whose brother Pete died from prostate cancer in December 2025, the news arrives with a profound sense of belatedness. Cossie, himself a prostate cancer survivor diagnosed in 2023, expressed that such screening should have been implemented much earlier.
The trial, named Transform, will assess the efficacy of additional tests beyond the standard PSA blood test. These include genetic assessments and rapid MRI scans, intended to boost the precision of early detection. This aligns with a broader government investment of £18 million into the trial.
Prostate cancer is the most prevalent cancer among men in the UK, leading to 12,000 deaths annually. While one in eight men will be diagnosed in their lifetime, this risk escalates to one in four for Black men, highlighting the urgent need for targeted interventions. The trial aims to establish a more effective screening system for the future, focusing on those most susceptible.
